跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRIASYN 5.0/5.0 tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
TRIASYN 5.0/5.0 tablet blister pack
Approved
STANDARD
TRIASYN 5.0/5.0 tablet blister pack
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
d8e8f9f464c8b4bf
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
d8e8f9f464c8b4bf
Product Name
TRIASYN 5.0/5.0 tablet blister pack
Artg Id
67183
Artg Name
TRIASYN 5.0/5.0 tablet blister pack
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
1998-12-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/7f6a76865473d78987d858b68b67ab98.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/22021fa51e5ac28d840f49818aefd5b8.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
d8e8f9f464c8b4bf
Type
Standard
Back to TGA Approvals